Founded in
Line of business
Products

Number of employees
Turnover

Business operation
locations
Marketing areas

1996
Biotechnology
Biosynthetic materials of medical applications
(e.g. recombinant collagens and gelatins)
20
(FibroGen Europe is in the research and
development phase)
Oulu, Helsinki

Europe

Reliable biosynthetic materials using gene technology

FibroGen Europe Corporation develops, commercialises, and produces biomaterials using gene technology for the pharmaceutical, medical device, and food manufacturing industries. The products include proteins, such as human collagen and gelatine, and animal collagen and gelatine. The products are produced using gene technology, the multigene method to be exact. The research and development are being carried out in co-operation with the parent company FibroGen Inc.